SCHEMBL2425899

SCHEMBL2425899

CC(O)c1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.53
CKS1B P61024 2/20 0.53
SKP1 P63208 2/20 0.53
SKP2 Q13309 2/20 0.53
DDB1 Q16531 1/20 0.52
CRBN Q96SW2 1/20 0.52
MAP4K4 O95819 1/20 0.51
RET P07949 5/20 0.49
PANK3 Q9H999 1/20 0.49
TBK1 Q9UHD2 1/20 0.49
OGA O60502 1/20 0.48
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428610 0.91 PANK3 (0.55) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL19283956 0.91 MAP4K4 (0.52) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL2426023 0.89 MAP4K4 (0.53) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL30893593 0.89 GPR119 (0.54) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL2122299 0.89 GPR119 (0.54) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL27980820 0.86 CKS1B (0.57) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL27827741 0.83 CKS1B (0.49) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL29890806 0.82 GPR119 (0.60) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL1594238 0.82 GPR119 (0.57) GPR119CKS1BSKP1SKP2DDB1
SCHEMBL13279435 0.82 GPR119 (0.60) GPR119CKS1BSKP1SKP2DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910168-B Tropane compounds EXELIXIS INC 2014-07-30 CN disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
CN-101910168-A Tropane compounds EXELIXIS INC 2010-12-08 CN disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 GPR119 1531/4885CKS1B 1562/4885SKP1 2688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.